Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,399 public trials 410 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Recruiting

Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma

NCT07057596

Conditions
Melanoma, Mestastatic Uveal Melanoma, Neoplasm Metastasis, +14 more
Locations
  • Charité - Universitätsmedizin Berlin Berlin, State of Berlin, Germany
  • Institut Catala d'Oncologia (ICO) Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital La Paz Madrid, Spain
  • Consorcio Hospital General Universitario de Valencia Valencia, Spain
View Trial Details
Recruiting

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

NCT04511013

Conditions
Acral Lentiginous Melanoma, Brain Diseases, Brain Neoplasms, +22 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
View all 331 locations
View Trial Details
Recruiting

A Study of BI 3810944 in Patients With Advanced Cancer

NCT07224425

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • University of Louisville Louisville, Kentucky, United States
  • Tennessee Oncology, PLLC - Elliston Place Plaza DDU Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • University of Virginia Health System Charlottesville, Virginia, United States
View Trial Details
Recruiting

SL-28 for Advanced Solid Tumours

NCT07341737

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +90 more
Locations
  • The Southern Oncology Clinical Research Unit (SOCRU) Adelaide, South Australia, Australia
  • Liverpool Hospital Sydney, New South Wales, Australia
  • John Flynn Private Hospital Gold Coast, Queensland, Australia
View Trial Details
Recruiting

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

NCT07804186

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +82 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of California, San Diego La Jolla, California, United States
View all 57 locations
View Trial Details

Related conditions